BSEBoard Meeting21 Oct 2026 · 21 Oct 2026, 05:04 pm
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter and half year ended September 30, 2026
Gland Pharma Ltd · 543245
✦ AI SummaryResults
Gland Pharma Ltd has scheduled a Board Meeting on November 06, 2026, to consider and approve Unaudited Financial Results for the Quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026